Загрузка...
Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin
PURPOSE: We aimed to compare the local control rates between miriplatin and epirubicin in lipiodol-based transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Patients who underwent targeted TACE using miriplatin (47 patients, 66 lesions) or epirubicin (64...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3346199/ https://ncbi.nlm.nih.gov/pubmed/22570565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S30431 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|